Bulletin
Investor Alert

Market Pulse Archives

Sept. 22, 2020, 12:53 p.m. EDT

Sanofi, GlaxoSmithKline signs deal with Canada to deliver 72 million doses of potential COVID-19 vaccine

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Sanofi ADR (SNY)
  • X
    Sanofi S.A. (SAN)
  • X
    GlaxoSmithKline PLC ADR (GSK)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Sanofi /zigman2/quotes/201967021/composite SNY +0.82% /zigman2/quotes/206928357/delayed FR:SAN +0.24% and GlaxoSmithKline PLC /zigman2/quotes/209463850/composite GSK +0.57% /zigman2/quotes/200381158/delayed UK:GSK +0.80% announced Tuesday that the companies have signed agreements with Canada to supply up to 72 million doses of their COVID-19 vaccine, starting in 2021. The companies had initiated a Phase 1/2 study on their vaccine candidate on Sept. 3, and expect first results in early December to support the initiation of a Phase 3 study before the end of the year. The companies said if the data is sufficient, they plan to request regulatory approval in the first half of 2021. "To address a global health crisis of this magnitude, it takes partnerships and we are grateful to Canada for its collaboration, and to [GlaxoSmithKline] for partnering with us to develop a safe and effective vaccine," said Thomas Triomphe, global head of Sanofi Pasteur. Separately, Moderna Inc. /zigman2/quotes/205619834/composite MRNA -0.44% said Canada has increased its order commitment to 20 million doses of the company's COVID-19 vaccine candidate, mRNA-1273. Moderna said its Phase 3 study has enrolled more than 75% of its participants. Shares of Sanofi have slipped 0.9% year to date, GlaxoSmithKline's stock has dropped 19.7% and Moderna's stock has soared 248.7%, while the S&P 500 /zigman2/quotes/210599714/realtime SPX +0.34% has gained 1.8%.

/zigman2/quotes/201967021/composite
US : U.S.: Nasdaq
$ 49.33
+0.40 +0.82%
Volume: 728,178
Oct. 23, 2020 4:00p
P/E Ratio
10.11
Dividend Yield
2.38%
Market Cap
$123.33 billion
Rev. per Employee
$390,092
loading...
/zigman2/quotes/206928357/delayed
FR : France: Euronext Paris
82.94
+0.20 +0.24%
Volume: 1.22M
Oct. 23, 2020 5:39p
P/E Ratio
9.37
Dividend Yield
3.80%
Market Cap
€104.20 billion
Rev. per Employee
€330,656
loading...
/zigman2/quotes/209463850/composite
US : U.S.: NYSE
$ 35.29
+0.20 +0.57%
Volume: 5.15M
Oct. 23, 2020 4:00p
P/E Ratio
10.55
Dividend Yield
5.68%
Market Cap
$87.24 billion
Rev. per Employee
$430,379
loading...
/zigman2/quotes/200381158/delayed
UK : U.K.: London
1,343.80 p
+10.60 +0.80%
Volume: 5.90M
Oct. 23, 2020 4:35p
P/E Ratio
10.09
Dividend Yield
5.95%
Market Cap
£66.89 billion
Rev. per Employee
N/A
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 70.53
-0.31 -0.44%
Volume: 3.74M
Oct. 23, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$27.83 billion
Rev. per Employee
$177,721
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,465.39
+11.90 +0.34%
Volume: 2.16B
Oct. 23, 2020 5:15p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.